The Retinitis Pigmentosa Treatment market was valued at USD 12.60 Billion in 2024 and is expected to reach USD 24.10 Billion by 2032, growing at a CAGR of 7.5% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.